These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14736286)

  • 1. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z; Hassan A; Pathan MH; White G
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
    Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
    Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.
    Ramalingam P; Rybicki L; Smith MD; Abrahams NA; Tubbs RR; Pettay J; Farver CF; Hsi ED
    Mod Pathol; 2002 Jun; 15(6):647-56. PubMed ID: 12065779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion.
    Vakiani E; Nandula SV; Subramaniyam S; Keller CE; Alobeid B; Murty VV; Bhagat G
    Hum Pathol; 2007 Feb; 38(2):315-25. PubMed ID: 17134734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
    Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Chen DB; Song QJ; Chen YX; Chen YH; Shen DH
    Int J Hematol; 2013 Jan; 97(1):117-24. PubMed ID: 23255160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
    Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
    Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
    Ranganathan S; Webber S; Ahuja S; Jaffe R
    Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
    Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
    Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
    Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
    Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation.
    Novoa-Takara L; Perkins SL; Qi D; Shidham VB; Vesole DH; Hariharan S; Luo Y; Ewton A; Chang CC
    Am J Clin Pathol; 2005 Jan; 123(1):104-12. PubMed ID: 15762285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.
    Harris NL; Ferry JA; Swerdlow SH
    Semin Diagn Pathol; 1997 Feb; 14(1):8-14. PubMed ID: 9044505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.
    Engels EA; Preiksaitis J; Zingone A; Landgren O
    Am J Transplant; 2012 May; 12(5):1268-74. PubMed ID: 22300426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.